Zhitong Finance App News, Haohai Biotechnology (06826) issued an announcement. On March 18, 2024, the company held the 21st meeting of the 5th board of directors to review the “Proposal on Granting Part 2 of the Company's 2021 A-share Restricted Stock Incentive Plan for the First Time to Meet the Vesting Conditions”. According to the authorization of the company's first extraordinary general meeting of shareholders in 2022, the first A-share class shareholders' meeting in 2022, and the first H-share class shareholders' meeting in 2022, the board of directors believes that the ownership requirements for the first time granted by the company's 2021 A share restricted stock incentive plan for the first time have been fulfilled, and the number of shares that can be attributed this time is 679,300 shares. It is agreed that the company will handle matters relating to the attribution of 191 eligible incentive recipients in accordance with the relevant provisions of this incentive plan.
昊海生物科技(06826)：67.93万股限制性股票获归属
Haohai Biotechnology (06826): 679,300 restricted shares were vested
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.